NIH/NSF funded principal investigators at The University of Maryland, Baltimore (UMB) have scientific needs for an 800 MHz nuclear magnetic resonance (NMR) spectrometer because of an increasing number of sophisticated NMR-based research projects. These include: 1. Dr. David J. Weber, Interaction of S 100 proteins with the tumor suppressor protein, p53; 2. Drs. Donna Baldisseri and Frank Margolis, Structure/function studies of OMP bound to Bex proteins; 3. Dr. Ronald Guiles, Structure/dynamic studies of cytochrome b5 and hIL-5; 4. Dr. Lindsay Black, Structure/function studies of T4 terminase; 5. Dr. John Collins, Interactions of skeletal muscle regulatory proteins; 6. Dr. Angela Wilks, Heteronuclear NMR studies of heme oxygenase; 7. Dr. Mordecai Blaustein, Structure/function studies of channel blocking toxins; 8. Dr. John Hamlyn, Biosynthesis and characterization of novel steroids; and 9. A new NMR spectroscopist to fill a tenure/tenure-track faculty position. In addition, seven other projects are briefly described in this application, which also have an essential need for an 800 MHz NMR spectrometer either now or in the very near future. The purchase of an 800 MHz NMR is an important component of the new UMB Center for Structural Biology that will include an expanded NMR center and X-ray crystallography. As part of this center, the 800 MHz spectrometer will be located in specially designed space in a new building in downtown Baltimore. The 800 MHz spectrometer will be one of two instruments in the UMB NMR shared facility; the other is an existing six year-old 600 MHz NMR spectrometer, which will be relocated into the Structural Biology Center. The users of the UMB NMR center include faculty members from the School of Medicine, the School of Pharmacy, the Greenebaum Cancer Center (GCC), and the University of Maryland Biotechnology Center (MBC). An established advisory committee, which has members from each of the above institutions, will continue to administer the management of the NMR facility including new policies for assuring equitable sharing of the NMR instrumentation. The cost of the 800 MHz NMR is approximately $1.9M, so a very large institutional commitment by the University is pledged. Because structural biology was identified as an important part of the strategic plan of this campus, several schools at the University of Maryland, Baltimore have agreed to continue their support of the UMB NMR center by providing the necessary matching funds towards the purchase and upkeep of this new instrument. These matching funds plus outstanding space to house the instrument represents a very large and necessary commitment to the field of structural biology by the University of Maryland, Baltimore.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-PB (01))
Program Officer
Tingle, Marjorie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Maryland Baltimore
Schools of Medicine
United States
Zip Code
Roth, Braden M; Godoy-Ruiz, Raquel; Varney, Kristen M et al. (2016) 1H, 13C, and 15N resonance assignments of an enzymatically active domain from the catalytic component (CDTa, residues 216-420) of a binary toxin from Clostridium difficile. Biomol NMR Assign 10:213-7
Cavalier, Michael C; Ansari, Mohd Imran; Pierce, Adam D et al. (2016) Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations. J Med Chem 59:592-608
McKnight, Laura E; Raman, E Prabhu; Bezawada, Padmavani et al. (2012) Structure-Based Discovery of a Novel Pentamidine-Related Inhibitor of the Calcium-Binding Protein S100B. ACS Med Chem Lett 3:975-979
Liriano, Melissa A; Varney, Kristen M; Wright, Nathan T et al. (2012) Target binding to S100B reduces dynamic properties and increases Ca(2+)-binding affinity for wild type and EF-hand mutant proteins. J Mol Biol 423:365-85
Malashkevich, Vladimir N; Dulyaninova, Natalya G; Ramagopal, Udupi A et al. (2010) Phenothiazines inhibit S100A4 function by inducing protein oligomerization. Proc Natl Acad Sci U S A 107:8605-10
Manvilla, Brittney A; Varney, Kristen M; Drohat, Alexander C (2010) Chemical shift assignments for human apurinic/apyrimidinic endonuclease 1. Biomol NMR Assign 4:5-8
Wilder, Paul T; Charpentier, Thomas H; Liriano, Melissa A et al. (2010) In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction. Int J High Throughput Screen 2010:109-126
Charpentier, Thomas H; Thompson, Laura E; Liriano, Melissa A et al. (2010) The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography. J Mol Biol 396:1227-43
Charpentier, Thomas H; Wilder, Paul T; Liriano, Melissa A et al. (2009) Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography. Biochemistry 48:6202-12
Wright, Nathan T; Cannon, Brian R; Zimmer, Danna B et al. (2009) S100A1: Structure, Function, and Therapeutic Potential. Curr Chem Biol 3:138-145

Showing the most recent 10 out of 21 publications